#416: Antifungals, Candida, Mucorales, Aspergillus, Pneumocystis: The Fungus Among Us with Dr. Ilan Schwartz MD

Nov 20, 2023, 08:00 AM

“I collect spores, molds and fungus” - Dr. Egon Spengler

Dr. Ilan Schwartz MD PhD (@GermHunterMD) teaches us that we should always at least consider fungi in the differential diagnosis of unexplained sepsis, especially in patients with impaired immune systems or complex medical or surgical histories, and walks us through an approach to antifungals.  Be sure to check out the Mycoses Study Group Education & Research Consortium (@MSG_ERC), an organization of clinicians who are dedicated to advancing diagnostics and treatment of fungal disease (where Dr. Schwartz serves on the board of directors!) Claim CME for this episode at curbsiders.vcuhealth.org!

Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME

Show Segments

  • Intro
  • Rapid fire questions, get to know our guest
  • Intentionally vague case; When should we be worried about fungal infection?
  • Overnight emergencies: Candidiasis and mucormycosis
  • Starting empiric anti-fungals
  • Testing basics: direct versus indirect
  • Fungemia, fungal endocarditis
  • Resistant candida; candida auris
  • Pneumocystis jiroveci pneumonia
  • Outro


  • Producer, Writer, Show Notes, Infographic/Cover Art: Beth Garbitelli MD
  • Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP, Beth Garbitelli MD
  • Reviewer: Emi Okamoto MD
  • Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP
  • Technical Production: PodPaste
  • Guest: Ilan Schwartz MD, PhD

Uncommon Goods

To get 15% off your next gift, go to uncommongoods.com/CURB.


Go to NetSuite.com/CURBSIDERS to get your own KPI Checklist. 


Get a comprehensive view of locums at locumstory.com.